| The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex JR Prensner, MK Iyer, A Sahu, IA Asangani, Q Cao, L Patel, IA Vergara, ... Nature genetics 45 (11), 1392-1398, 2013 | 716 | 2013 |
| Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy N Erho, A Crisan, IA Vergara, AP Mitra, M Ghadessi, C Buerki, ... PloS one 8 (6), e66855, 2013 | 652 | 2013 |
| The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer D Chakravarty, A Sboner, SS Nair, E Giannopoulou, R Li, S Hennig, ... Nature communications 5 (1), 5383, 2014 | 591 | 2014 |
| Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population RJ Karnes, EJ Bergstralh, E Davicioni, M Ghadessi, C Buerki, AP Mitra, ... The Journal of urology 190 (6), 2047-2053, 2013 | 358 | 2013 |
| UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas SQ Wong, K Waldeck, IA Vergara, J Schröder, J Madore, JS Wilmott, ... Cancer research 75 (24), 5228-5234, 2015 | 332 | 2015 |
| StAR: a simple tool for the statistical comparison of ROC curves IA Vergara, T Norambuena, E Ferrada, AW Slater, F Melo BMC bioinformatics 9, 1-5, 2008 | 213 | 2008 |
| A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy AE Ross, FY Feng, M Ghadessi, N Erho, A Crisan, C Buerki, D Sundi, ... Prostate cancer and prostatic diseases 17 (1), 64-69, 2014 | 153 | 2014 |
| The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer JR Prensner, A Sahu, MK Iyer, R Malik, B Chandler, IA Asangani, ... Oncotarget 5 (6), 1434, 2014 | 117 | 2014 |
| Circulating tumor DNA analysis and functional imaging provide complementary approaches for comprehensive disease monitoring in metastatic melanoma SQ Wong, JM Raleigh, J Callahan, IA Vergara, S Ftouni, A Hatzimihalis, ... Precision Oncology 1, 1-14, 2017 | 108 | 2017 |
| Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma S AbuHammad, C Cullinane, C Martin, Z Bacolas, T Ward, H Chen, ... Proceedings of the National Academy of Sciences 116 (36), 17990-18000, 2019 | 88 | 2019 |
| A community-based model of rapid autopsy in end-stage cancer patients K Alsop, H Thorne, S Sandhu, A Hamilton, C Mintoff, E Christie, O Spruyt, ... Nature biotechnology 34 (10), 1010-1014, 2016 | 84 | 2016 |
| Using the generic synteny browser (GBrowse_syn) SJ McKay, IA Vergara, JE Stajich Current protocols in bioinformatics 31 (1), 9.12. 1-9.12. 25, 2010 | 76 | 2010 |
| Multi-institutional analysis shows that low PCAT-14 expression associates with poor outcomes in prostate cancer NM White, SG Zhao, J Zhang, EB Rozycki, HX Dang, SD McFadden, ... European urology 71 (2), 257-266, 2017 | 72 | 2017 |
| Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer AK Kaushik, SK Vareed, S Basu, V Putluri, N Putluri, K Panzitt, ... Journal of proteome research 13 (2), 1088-1100, 2014 | 67 | 2014 |
| The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis X Zhang, L Yang, P Szeto, GK Abali, Y Zhang, A Kulkarni, K Amarasinghe, ... Oncogene 39 (30), 5267-5281, 2020 | 64 | 2020 |
| Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome PJ Hurley, L Marchionni, BW Simons, AE Ross, SB Peskoe, RM Miller, ... Proceedings of the National Academy of Sciences 109 (37), 14977-14982, 2012 | 60 | 2012 |
| OrthoCluster: a new tool for mining synteny blocks and applications in comparative genomics X Zeng, MJ Nesbitt, J Pei, K Wang, IA Vergara, N Chen Proceedings of the 11th international conference on Extending database …, 2008 | 58 | 2008 |
| Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling IA Vergara, CP Mintoff, S Sandhu, L McIntosh, RJ Young, SQ Wong, ... Nature communications 12 (1), 1434, 2021 | 57 | 2021 |
| Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer AP Mitra, LL Lam, M Ghadessi, N Erho, IA Vergara, M Alshalalfa, C Buerki, ... Journal of the National Cancer Institute 106 (11), dju290, 2014 | 55 | 2014 |
| Tumour gene expression signature in primary melanoma predicts long-term outcomes M Garg, DL Couturier, J Nsengimana, NA Fonseca, M Wongchenko, ... Nature communications 12 (1), 1137, 2021 | 45 | 2021 |
